Pediatric allergy prediction has taken a significant step forward with new research focusing on the placenta. Allergies represent the most common and earliest onset non-communicable diseases in children worldwide. Therefore, identifying high-risk infants at birth could revolutionize early intervention and prevention strategies. Recently, researchers investigated placental glucocorticoid-regulated mRNA profiles to determine if they can forecast future allergic outcomes effectively.

Advancements in Pediatric Allergy Prediction

The study included two distinct populations in Australia, analyzing a total of 366 placentae. Researchers utilized qPCR to measure various glucocorticoid-regulated genes. This advanced statistical modeling identified five specific genes—AFF1, ARID5B, IER3, ATF4, and SLC19A2—as the top-ranking predictors. Although the best-performing model achieved a moderate AUC of 0.664, it demonstrated exceptional specificity in its results. Specifically, these markers excel at identifying children who will not develop allergies. This distinction indicates that the placentae of non-allergic and allergic children are transcriptionally unique from the moment of birth.

Furthermore, this discovery supports the hypothesis that allergy origins lie in early developmental events. Prenatal exposures and placental health appear to play a critical role in immune system programming. Consequently, clinicians might soon use placental screening to monitor infant health more effectively during the neonatal period. While sensitivity requires further refinement in future studies, this trial provides a robust foundation for next-generation diagnostic tools. Scientists believe that early identification will ultimately reduce the long-term impact of allergic diseases on pediatric patients.

FAQs

Can we predict childhood allergies at birth?

Yes, recent research suggests that analyzing placental glucocorticoid-regulated genes can help in pediatric allergy prediction. It is particularly effective at identifying children who are unlikely to develop allergies later in life.

Which specific genes are involved in this prediction?

The study identified five key genes: AFF1, ARID5B, IER3, ATF4, and SLC19A2. These genes show distinct expression patterns in the placentae of children who do not develop allergies.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional opinion. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Clifton VL et al. A Phase 1 Prognostic Trial for Predicting Paediatric Allergy Using the Placenta at Birth. Clin Exp Allergy. 2026 Mar 07. doi: 10.1111/cea.70272. PMID: 41795204.

National Institute of Allergy and Infectious Diseases (NIAID). (2024). Fetal Immune System Development and Allergy Risk.

World Allergy Organization. (2023). Global Perspectives on Early Life Allergy Prevention.